Levomilnacipran SR Pellets Manufacturer in India

Levomilnacipran SR Pellets Manufacturer in India

Pharmaceutical-Grade Levomilnacipran SR Pellets for Sustained-Release Oral Formulations

Levomilnacipran SR Pellets are multiparticulate pharmaceutical formulations designed for sustained-release oral dosage applications. The active ingredient is Levomilnacipran Hydrochloride, identified by CAS Number 175131-60-9, molecular formula C₁₅H₂₃ClN₂O, and molecular weight 282.81 g/mol. PubChem confirms these chemical identifiers for Levomilnacipran Hydrochloride.

The SDP pellet product portfolio lists Levomilnacipran SR Pellets at 25% strength, providing a defined active-loading option for pharmaceutical formulation development.

The sustained-release pellet format provides a multiparticulate platform designed to modify the release profile of the active ingredient. Such pellets can be incorporated into suitable oral dosage forms, including capsule-filling applications. Final release performance depends on the formulation composition, coating system, active loading, pellet characteristics and applicable finished-product specification.

Key Features

• Levomilnacipran sustained-release pharmaceutical pellets
• 25% active ingredient strength
• Pharmaceutical-grade multiparticulate formulation
• Sustained-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Defined active ingredient loading
• Product-specific release characteristics
• Formulation flexibility
• Suitable for bulk pharmaceutical requirements

Product Information

Levomilnacipran Hydrochloride is the hydrochloride salt of Levomilnacipran. PubChem reports CAS 175131-60-9, molecular formula C₁₅H₂₃ClN₂O, and molecular weight 282.81 g/mol. The free-base Levomilnacipran is identified separately as CAS 96847-54-0, with formula C₁₅H₂₂N₂O and molecular weight 246.35 g/mol.

For the finished pellet product, the 25% value represents active ingredient loading and should not be confused with the purity assay of the Levomilnacipran Hydrochloride raw material.

Available Strength

Levomilnacipran SR Pellets — 25%

The 25% strength is listed for Levomilnacipran SR Pellets in the referenced pellet product portfolio.

Applications

Levomilnacipran SR Pellets can be considered for:

• Sustained-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Modified-release formulation development
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Levomilnacipran SR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 25% Strength: Defined active-loading option for formulation development.
• Sustained-Release Format: Designed for sustained-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
• Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
• Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Levomilnacipran SR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp